- Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic medsScribe Therapeutics has put its IPO plans down on paper, showing the genetic medicine company hopes to raise $96 million through its public listing.Fierce Biotech · 7d ago↗ source
- BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’Bristol Myers Squibb has entered into an expanded collaboration with Nvidia to create the biggest supercomputer for drug R&D, according to the announcement.Fierce Biotech · 7d ago↗ source
- Opinion: My husband’s suicide shows there’s something very wrong with the U.S. insurance industry“My love for Randy and my professional experience were not enough to save him,” a physician writes about her husband’s suicide.